<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="35664">Statins</z:chebi> have recently been shown to exert neuronal protection in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Reactive oxygen species, specifically <z:chebi fb="1" ids="18421">superoxide</z:chebi> formed during the early phase of reperfusion, augment neuronal injury </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase is a key enzyme for <z:chebi fb="1" ids="18421">superoxide</z:chebi> production </plain></SENT>
<SENT sid="3" pm="."><plain>The present study tested the hypothesis that <z:chebi fb="0" ids="39548">atorvastatin</z:chebi> protects against <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> via inhibition of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase-derived <z:chebi fb="1" ids="18421">superoxide</z:chebi> in transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was created in <z:chebi fb="2" ids="5615">halothane</z:chebi>-anesthetized adult male Sprague-Dawley rats (250-300 g) by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="39548">Atorvastatin</z:chebi> (<z:chebi fb="0" ids="50686">Lipitor</z:chebi>, 10 mg/kg sc) was administered three times before MCAO </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was measured by triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase enzymatic activity and <z:chebi fb="1" ids="18421">superoxide</z:chebi> levels were quantified in the ischemic core and penumbral regions by lucigenin (5 microM)-enhanced chemiluminescence </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase membrane subunit gp91(phox) and membrane-translocated subunit p47(phox) and small GTPase Rac-1 was analyzed by Western blot </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase activity and <z:chebi fb="1" ids="18421">superoxide</z:chebi> levels increased after reperfusion and peaked within 2 h of reperfusion in the penumbra, but not in the ischemic core, in MCAO rats </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="39548">Atorvastatin</z:chebi> pretreatment prevented these increases, blunted expression of membrane subunit gp91(phox), and prevented translocation of cytoplasmic subunit p47(phox) to the membrane in the penumbra 2 h after reperfusion </plain></SENT>
<SENT sid="11" pm="."><plain>Consequently, cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was significantly reduced in <z:chebi fb="0" ids="39548">atorvastatin</z:chebi>-treated compared with nontreated MCAO rats 24 h after reperfusion </plain></SENT>
<SENT sid="12" pm="."><plain>These results indicate that <z:chebi fb="0" ids="39548">atorvastatin</z:chebi> protects against <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> via inhibition of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase-derived <z:chebi fb="1" ids="18421">superoxide</z:chebi> in transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>